Assessing the history and value of Human Genome Sciences

Journal of Commercial Biotechnology

Volumn 19, Issue 4, 2013, Pages 3-10

  McNamee, Laura M ^a   Ledley, Fred D ^a  

^a BENTLEY UNIVERSITY   (United States)

Author keywords

Accounting; Biotechnology; Drug development; Genomics; Investment; Value

Indexed keywords

ACCOUNTING PRACTICES; ACQUISITION PRICE; DRUG DEVELOPMENT; GENOMICS; HIGHLY-CORRELATED; MARKET POTENTIAL; TOTAL CAPITAL INVESTMENTS; VALUE;

BIOTECHNOLOGY; COMMERCE; GENE THERAPY; NUCLEAR FUEL ACCOUNTING;

INVESTMENTS;

ACCOUNTING; CALCULATION; CONFERENCE PAPER; EXPRESSED SEQUENCE TAG; HUMAN; HUMAN GENOME; INVESTMENT; PATENT; PRODUCT DEVELOPMENT; PROFIT; SCIENCE;

EID: 84885414626     PISSN: 14628732     EISSN: 1478565X     Source Type: Journal    
DOI: 10.5912/jcb.619     Document Type: Conference Paper

References (17)

1. GSK. GSK completes acquistion of Human Genome Sciences. Press Release (2012
2. HGS. (1993). S-1 filing. SEC document.
3. Kirknew, E.F. & Kerlavage, A.R. The TIGR Human cDNA Database, Methods in Molecular Biology, Vol. 69. (Humana Press Inc., Totowa, NJ; 1997
4. HGS. 1998 Annual Report. SEC Document (1998
5. HGS. Human Genome Sciences Announces Second Quarter 2002 Financial Results. Press Release (2002
6. DiMasi, J.A., Feldman, L., Seckler, A. & Wilson, A. (2010). Trends in risks associated with new drug development: success rates for investigational drugs. Clin Pharmacol Ther 87, 272-277.
7. Kim, S. & Hirschler, B. Exclusive: Human Genome rejected Amgen's $7 billion bid in 2010:sources. Reuters (2012
8. Center for Disease Control. Systemic lupus erythematosus (SLE or lupus). www.cdc.gov/arthritis/basics/lupus.htm (2012
9. Istockanalyst. Should you invest in Human Genome Sciences Inc. (NASDAQ:HGSI)? ( 2011
10. Lehman Brothers and McKinsey. The fruits of genomics. New York (2001
11. Schneider, P. et al. BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth. J Exp Med 189, 1747-1756 (1999
12. Shu, H.B., Hu, W.H. & Johnson, H. TALL-1 is a novel member of the TNF family that is down-regulated by mitogens. Journal of Leukocyte Biology 65, 680-683 (1999
13. Mukhopadhyay, A., Ni, J., Zhai, Y., Yu, G.-L. & Aggarwal, B.B. Identification and Characterization of a Novel Cytokine, THANK, aTNF Homologue That ActivatesApoptosis, Nuclear Factor-?B, and c-Jun NH2-Terminal Kinase. Journal of Biological Chemistry 274, 15978-15981 (1999
14. Moore, P.A. et al. BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator. Science 285, 260-263 (1999
15. Tribouley, C. et al. Characterization of a new member of the TNF family expressed on antigen presenting cells. Biol Chem 380, 1443-1447 (1999
16. GSK. GSK continues with tender offer to acquire all outstanding shares of Human Genome Sciences. Press Release (2012
17. Pisano, G.P. Science Business: The promise, the reality, and the future of biotech. (Harvard Business School Press, Boston; 2006).